PolyPid

PYPD · NASDAQ

$5.15+$0.27 (+5.53%)TodayMarket closed · Oct 20, 7:30 PM ET

Prev close $4.88

Latest news

Press releaseOct 1, 9:15 AM ETGlobe Newswire
European Medicines Agency Validates PolyPid’s Marketing Authorization Application for D-PLEX₁₀₀
Press releaseOct 1, 8:56 AM ETGlobe Newswire
PolyPid Regains European Commercialization Rights for D-PLEX₁₀₀, Expanding Global Commercialization Opportunities
Press releaseSep 15, 8:30 AM ETGlobe Newswire
PolyPid Announces Participation in Upcoming Fall Investor Conferences
Press releaseAug 12, 7:30 AM ETGlobe Newswire
PolyPid Provides Corporate Update and Reports Second Quarter 2026 Financial Results
NewsJul 29, 8:34 AM ET
PolyPid Announces FDA Acceptance Of Its New Drug Application With A Priority Review For D-PLEX100 For The Prevention Of Surgical Site Infections In Patients Undergoing Abdominal Colorectal Surgery; PDUFA Action Date Is November 28
Press releaseJul 29, 8:30 AM ETGlobe Newswire
PolyPid Announces FDA Acceptance of NDA with Priority Review for D-PLEX₁₀₀
NewsJul 21, 7:32 AM ET
PolyPid Signs Agreement With Azurity Pharmaceuticals To Commercialize D-PLEX100 In U.S., Canada To Prevent Surgical Site Infections; PolyPid To Receive $15M Upfront Payment
Press releaseJul 21, 7:30 AM ETGlobe Newswire
PolyPid Announces Exclusive Partnership with Azurity Pharmaceuticals for the Commercialization of D-PLEX₁₀₀ in the U.S. and Canada
Press releaseJun 1, 8:30 AM ETGlobe Newswire
PolyPid Completes New Drug Application Submission to FDA for D-PLEX₁₀₀
NewsMay 13, 9:24 AM ET
PolyPid Q1 2026 Earnings Call: Complete Transcript
NewsMay 13, 7:11 AM ET
Earnings Scheduled For May 13, 2026
NewsFeb 11, 6:11 AM ET
Earnings Scheduled For February 11, 2026
NewsFeb 10, 3:02 PM ET
Preview: PolyPid's Earnings
NewsNov 12, 6:11 AM ET
Earnings Scheduled For November 12, 2025
NewsAug 18, 8:08 AM ET
12 Health Care Stocks Moving In Monday's Pre-Market Session
NewsAug 13, 4:32 AM ET
Earnings Scheduled For August 13, 2025
NewsJun 9, 12:53 PM ETVandana Singh
Nano-Cap PolyPid's Lead Drug Candidate Cuts Surgical Infection Risk by 38% In Phase 3 Trial
Press releaseJun 9, 8:54 AM ETGlobe Newswire
BriefCast Publishes Transcript: PolyPid Ltd. SHIELD II Phase 3 Trial Topline Results Call Transcript
NewsMay 14, 4:32 AM ET
Earnings Scheduled For May 14, 2025
NewsMay 13, 2:02 PM ET
A Look Ahead: PolyPid's Earnings Forecast
NewsNov 12, 11:02 AM ET
PolyPid's Earnings: A Preview
NewsJul 29, 1:19 PM ETAvi Kapoor
Why Bank of Marin Bancorp Shares Are Trading Lower? Here Are Other Stocks Moving In Monday's Mid-Day Session

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

European Medicines Agency Validates PolyPid’s Marketing Authorization Application for D-PLEX₁₀₀

PolyPid Regains European Commercialization Rights for D-PLEX₁₀₀, Expanding Global Commercialization Opportunities

PolyPid Announces Participation in Upcoming Fall Investor Conferences

PolyPid Provides Corporate Update and Reports Second Quarter 2026 Financial Results

PolyPid Announces FDA Acceptance Of Its New Drug Application With A Priority Review For D-PLEX100 For The Prevention Of Surgical Site Infections In Patients Undergoing Abdominal Colorectal Surgery; PDUFA Action Date Is November 28

PolyPid Announces FDA Acceptance of NDA with Priority Review for D-PLEX₁₀₀

PolyPid Signs Agreement With Azurity Pharmaceuticals To Commercialize D-PLEX100 In U.S., Canada To Prevent Surgical Site Infections; PolyPid To Receive $15M Upfront Payment

PolyPid Announces Exclusive Partnership with Azurity Pharmaceuticals for the Commercialization of D-PLEX₁₀₀ in the U.S. and Canada

PolyPid Completes New Drug Application Submission to FDA for D-PLEX₁₀₀

PolyPid Q1 2026 Earnings Call: Complete Transcript

Earnings Scheduled For May 13, 2026

Earnings Scheduled For February 11, 2026

Preview: PolyPid's Earnings

Earnings Scheduled For November 12, 2025

12 Health Care Stocks Moving In Monday's Pre-Market Session

Earnings Scheduled For August 13, 2025

Nano-Cap PolyPid's Lead Drug Candidate Cuts Surgical Infection Risk by 38% In Phase 3 Trial

BriefCast Publishes Transcript: PolyPid Ltd. SHIELD II Phase 3 Trial Topline Results Call Transcript

Earnings Scheduled For May 14, 2025

A Look Ahead: PolyPid's Earnings Forecast

PolyPid's Earnings: A Preview

Why Bank of Marin Bancorp Shares Are Trading Lower? Here Are Other Stocks Moving In Monday's Mid-Day Session